China using decade-old arthritis drug to treat COVID-19
Chinese health authorities now recommend the use of Roche`s drug for rheumatoid arthritis, Actemra, in the treatment of serious novel coronavirus patients.
The Chinese health authorities now recommend the use of Roche`s drug for rheumatoid arthritis, Actemra, in the treatment of serious novel coronavirus patients, the media reported.
China`s National Health Commission made the recommendation in the updated treatment guidelines for COVID-19 released on Wednesday, pharma industry news site FiercePharma reported.
See Zee Business live streaming below:
The decision was taken after seeing promising results in clinical practice.
The Swiss drugmaker donated nearly $2 million worth of Actemra to China, its local operations said in a blog post on Monday.
The donation was made last week after a scientist at the Chinese Academy of Sciences said that promising results had been observed in 14 serious and critically ill patients treated with existing medicines at a hospital affiliated with the University of Science and Technology of China (USTC).
As per the revelations made by USTC, the regimen includes Actemra. A randomized clinical trial evaluating the drug`s application has already been started there.
Actemra is known as an inhibitor of the receptor of interleukin 6 (IL-6), a pro-inflammatory cytokine.
A research team consisting of respiratory specialists from the Wuhan-based Tongji Hospital, central China`s Hubei province, found that critically ill patients had the most interleukin-2 receptor (IL-2R) and interleukin-6 (IL-6) in their serum, while the patients with mild pneumonia had the least, which showed that the severity of the disease is positively correlated with the expression levels of the two serum cytokines.
The national diagnosis and treatment plan for COVID-19 unveiled by the Chinese health authorities on Wednesday includes the results of autopsies of COVID-19 victims and pathological observation based on needle biopsies, Xinhua reported.
China has added the antibody diagnosis method for COVID-19 and its relevant criteria in the country`s latest diagnosis and treatment scheme, which also includes warning against transmission of the novel coronavirus via aerosol or contact due to environmental pollution caused by the excrement and urine of patients.
Roche`s Actemra drug was first approved by the U.S. Food and Drug Administration (FDA) in 2010.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
If you make RDs of Rs 5,000, Rs 10,000, Rs 15,000, and Rs 20,000 in post office, what will be your maturity amount?
Special Live Trading Session on Saturday: Know why BSE, NSE will remain open on May 18; check timings
RCB vs CSK IPL 2024 Ticket Booking Online: Where and how to buy RCB vs CSK tickets online - Check IPL Match 68 ticket price, other details
Women loco pilots speak about their struggle; many men have to be informed even for 'washroom break' in a moving train
Bandhan Bank Q4 FY24 Results Preview: PAT, interest income likely to grow in almost double digits; asset quality may improve
09:58 AM IST